Wellness Innercell Expands into Indonesia Through Surabaya Representative Office Partnership

Wellness Innercell Expands into Indonesia Through Surabaya Representative Office Partnership

SEOUL, South Korea, June 19, 2026 /PRNewswire/ -- Wellness Innercell, a healthcare company specializing in health supplements and beauty products, announced that it has signed a representative office partnership agreement in Surabaya, Indonesia,...

KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"

KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"

- Foreign ownership rises to 51% based on strong overseas performance and enhanced shareholder returns - CEO Bang Kyung-man and senior management actively communicate with global investors through Overseas Non-Deal Roadshows (NDRs) SEOUL, South...

KT&G: "U.S. investor Capital Research and Management Company Increases stake from 5.6% to 7.2%"

KT&G: "U.S. investor Capital Research and Management Company Increases stake from 5.6% to 7.2%"

Announces further acquisition after acquisition of 5.61% in May 8th KT&G sees growth in Q1 based on global cigarette business growth—plans to announces new shareholder return policy in H2 SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- KT&G...

Goodman plans new data centre campus development in Sagamihara City, Greater Tokyo

Goodman plans new data centre campus development in Sagamihara City, Greater Tokyo

SAGAMIHARA, Japan, May 28, 2026 /PRNewswire/ -- Goodman Group (ASX:GMG), a global provider of essential infrastructure, has been selected as the lead development partner for an association of local landowners and stakeholders advancing plans for a...

Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS

Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS

CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical...

Hyundai Mobis Seeks Robotics Technology Alliances in U.S. Silicon Valley!

Hyundai Mobis Seeks Robotics Technology Alliances in U.S. Silicon Valley!

- Mobis hosts the "5th Mobis Mobility Day," open innovation event under the theme of "Robotics and Physical AI" - Attendance by representatives from startups, global automakers, and investors doubles from last year, reflecting the achievements...

TDengine Reports 100% Growth Across Key Markets and Major Product Milestones in 2025

TDengine Reports 100% Growth Across Key Markets and Major Product Milestones in 2025

LOS GATOS, Calif., Jan. 20, 2026 /PRNewswire/ -- TDengine today announced steady growth across key markets in 2025, closing a year defined by product expansion, ecosystem development, and continued adoption by industrial customers modernizing their...

MOVA Launches Cleaning Solutions in Silicon Valley: Finding Answers for Premium Cleaning Through Pragmatic Innovation

MOVA Launches Cleaning Solutions in Silicon Valley: Finding Answers for Premium Cleaning Through Pragmatic Innovation

SAN JOSE, Calif., Jan. 16, 2026 /PRNewswire/ -- Technology is no longer a distant, high-level concept, but something that truly serves users. At the M∞VA Universe integrated smart indoor technologies launch in Silicon Valley on January 15, 2026,...

Sky Labs Secures CE-MDR for 'CART PLATFORM,' Accelerating Its Global Market Entry

Sky Labs Secures CE-MDR for 'CART PLATFORM,' Accelerating Its Global Market Entry

- 'CART,' the blood pressure ring, recognized in Europe for its advanced vital sign monitoring technology - Targeting the global healthcare market beyond Europe through CE-MDR certification SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- Sky Labs...

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on core technologies, including expansion of indications for the Grabody platform SEOUL, South...

  • 1
  • 2
  • 3
  • 4
  • 5
  • menu
    menu